Hanover Insurance (THG) — insider trading
Financials · NYSE
Hanover Insurance (THG) has 101 reported SEC Form 4 insider transactions in our data, including 22 open-market sales among the most recent 100 (latest 2026-09-25).
Recent Form 4 transactions
Showing the 100 most recent of 101 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | RAMRATH JOSEPH R | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | LANE KATHY S | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Ward Elizabeth A | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Salvatore Bryan J | Officer (Executive Vice President) | Grant / award / vesting | 24 | — | $0 | Form 4 |
| 2026-09-25 | Roche John C | Director, Officer (President and CEO) | Grant / award / vesting | 120 | — | $0 | Form 4 |
| 2026-09-25 | Norton-Gatto Patricia A. | Officer (SVP & Princpl. Accntg. Officer) | Grant / award / vesting | 6 | — | $0 | Form 4 |
| 2026-09-25 | LOVELY DAVID JOHN | Officer (Executive Vice President) | Grant / award / vesting | 10 | — | $0 | Form 4 |
| 2026-09-25 | Lee Willard T | Officer (Executive Vice President) | Grant / award / vesting | 11 | — | $0 | Form 4 |
| 2026-09-25 | LAVEY RICHARD W | Officer (Executive Vice President) | Grant / award / vesting | 28 | — | $0 | Form 4 |
| 2026-09-25 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Grant / award / vesting | 15 | — | $0 | Form 4 |
| 2026-09-25 | FARBER JEFFREY M | Officer (Executive Vice President) | Grant / award / vesting | 42 | — | $0 | Form 4 |
| 2026-09-25 | Egan Cynthia | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Donnell William E. | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Condrin J Paul | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Carlin Jane D | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Bunting Theodore H JR | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Bradicich Kevin | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-09-25 | Aristeguieta Francisco | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-08-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 2,104 | — | $0 | Form 4 |
| 2026-08-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Open-market sale | 1,704 | $222.97 | $379.9K | Form 4 |
| 2026-08-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Open-market sale | 400 | $220.01 | $88.0K | Form 4 |
| 2026-08-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Option exercise / conversion | 2,104 | $118.54 | $249.4K | Form 4 |
| 2026-08-19 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 6,551 | — | $0 | Form 4 |
| 2026-08-19 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Open-market sale | 224 | $222.77 | $49.9K | Form 4 |
| 2026-08-19 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Open-market sale | 1,505 | $221.73 | $333.7K | Form 4 |
| 2026-08-19 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Open-market sale | 4,822 | $220.41 | $1.06M | Form 4 |
| 2026-08-19 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Option exercise / conversion | 6,551 | $118.54 | $776.6K | Form 4 |
| 2026-08-06 | Bunting Theodore H JR | Director | Open-market sale | 600 | $230.20 | $138.1K | Form 4 |
| 2026-08-05 | Bunting Theodore H JR | Director | Open-market sale | 600 | $228.03 | $136.8K | Form 4 |
| 2026-08-03 | Carlin Jane D | Director | Open-market sale | 1,000 | $231.50 | $231.5K | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 19,084 | — | $0 | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 26,832 | — | $0 | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 20,379 | — | $0 | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Shares withheld for taxes / exercise cost | 49,330 | $232.34 | $11.46M | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Option exercise / conversion | 19,084 | $115.35 | $2.20M | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Option exercise / conversion | 26,832 | $118.54 | $3.18M | Form 4 |
| 2026-07-29 | FARBER JEFFREY M | Officer (Executive Vice President) | Option exercise / conversion | 20,379 | $117.22 | $2.39M | Form 4 |
| 2026-06-26 | FARBER JEFFREY M | Officer (Executive Vice President) | Grant / award / vesting | 43 | — | $0 | Form 4 |
| 2026-06-26 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Grant / award / vesting | 15 | — | $0 | Form 4 |
| 2026-06-26 | LAVEY RICHARD W | Officer (Executive Vice President) | Grant / award / vesting | 28 | — | $0 | Form 4 |
| 2026-06-26 | Lee Willard T | Officer (Executive Vice President) | Grant / award / vesting | 11 | — | $0 | Form 4 |
| 2026-06-26 | LOVELY DAVID JOHN | Officer (Executive Vice President) | Grant / award / vesting | 11 | — | $0 | Form 4 |
| 2026-06-26 | Norton-Gatto Patricia A. | Officer (SVP & Princpl. Accntg. Officer) | Grant / award / vesting | 6 | — | $0 | Form 4 |
| 2026-06-26 | Roche John C | Director, Officer (President and CEO) | Grant / award / vesting | 122 | — | $0 | Form 4 |
| 2026-06-26 | Salvatore Bryan J | Officer (Executive Vice President) | Grant / award / vesting | 25 | — | $0 | Form 4 |
| 2026-06-26 | Ward Elizabeth A | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | RAMRATH JOSEPH R | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Condrin J Paul | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Aristeguieta Francisco | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Bradicich Kevin | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Donnell William E. | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Bunting Theodore H JR | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Carlin Jane D | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | Egan Cynthia | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-26 | LANE KATHY S | Director | Grant / award / vesting | 4 | — | $0 | Form 4 |
| 2026-06-03 | Salvatore Bryan J | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 16,394 | — | $0 | Form 4 |
| 2026-06-03 | Salvatore Bryan J | Officer (Executive Vice President) | Open-market sale | 16,394 | $185.76 | $3.05M | Form 4 |
| 2026-06-03 | Salvatore Bryan J | Officer (Executive Vice President) | Option exercise / conversion | 16,394 | $104.11 | $1.71M | Form 4 |
| 2026-05-21 | Aristeguieta Francisco | Director | Open-market sale | 1,000 | $195.37 | $195.4K | Form 4 |
| 2026-05-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 6,262 | — | $0 | Form 4 |
| 2026-05-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Open-market sale | 6,262 | $192.99 | $1.21M | Form 4 |
| 2026-05-20 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Option exercise / conversion | 6,262 | $115.35 | $722.3K | Form 4 |
| 2026-05-20 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 61 | $194.77 | $11.9K | Form 4 |
| 2026-05-20 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 5,145 | $194.05 | $998.4K | Form 4 |
| 2026-05-20 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 3,152 | $193.21 | $609.0K | Form 4 |
| 2026-05-19 | Roche John C | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 24,026 | — | $0 | Form 4 |
| 2026-05-19 | Roche John C | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 9,098 | — | $0 | Form 4 |
| 2026-05-19 | Roche John C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 24,766 | $193.79 | $4.80M | Form 4 |
| 2026-05-19 | Roche John C | Director, Officer (President and CEO) | Option exercise / conversion | 24,026 | $104.11 | $2.50M | Form 4 |
| 2026-05-19 | Roche John C | Director, Officer (President and CEO) | Option exercise / conversion | 9,098 | $85.87 | $781.2K | Form 4 |
| 2026-05-18 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 100 | $199.23 | $19.9K | Form 4 |
| 2026-05-18 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 2,516 | $198.65 | $499.8K | Form 4 |
| 2026-05-18 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 2,260 | $197.61 | $446.6K | Form 4 |
| 2026-05-18 | Roche John C | Director, Officer (President and CEO) | Open-market sale | 375 | $196.55 | $73.7K | Form 4 |
| 2026-05-15 | Roche John C | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 18,194 | — | $0 | Form 4 |
| 2026-05-15 | Roche John C | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 12,943 | $194.64 | $2.52M | Form 4 |
| 2026-05-15 | Roche John C | Director, Officer (President and CEO) | Option exercise / conversion | 18,194 | $85.87 | $1.56M | Form 4 |
| 2026-05-14 | Lowsley Denise | Officer (Executive Vice President) | Option exercise / conversion (derivative) | 4,175 | — | $0 | Form 4 |
| 2026-05-14 | Lowsley Denise | Officer (Executive Vice President) | Open-market sale | 4,175 | $191.73 | $800.5K | Form 4 |
| 2026-05-14 | Lowsley Denise | Officer (Executive Vice President) | Option exercise / conversion | 4,175 | $115.35 | $481.6K | Form 4 |
| 2026-05-12 | Egan Cynthia | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Carlin Jane D | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Aristeguieta Francisco | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Bradicich Kevin | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Bunting Theodore H JR | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Condrin J Paul | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | RAMRATH JOSEPH R | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | LANE KATHY S | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Ward Elizabeth A | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-12 | Donnell William E. | Director | Grant / award / vesting | 843 | — | $0 | Form 4 |
| 2026-05-08 | Lowsley Denise | Officer (Executive Vice President) | Open-market sale | 1,062 | $188.43 | $200.1K | Form 4 |
| 2026-05-04 | Lee Willard T | Officer (Executive Vice President) | Open-market sale | 1,000 | $183.93 | $183.9K | Form 4 |
| 2026-05-01 | Egan Cynthia | Director | Open-market sale | 3,400 | $188.50 | $640.9K | Form 4 |
| 2026-03-27 | Salvatore Bryan J | Officer (Executive Vice President) | Grant / award / vesting | 31 | — | $0 | Form 4 |
| 2026-03-27 | Roche John C | Director, Officer (President and CEO) | Grant / award / vesting | 153 | — | $0 | Form 4 |
| 2026-03-27 | LAVEY RICHARD W | Officer (Executive Vice President) | Grant / award / vesting | 35 | — | $0 | Form 4 |
| 2026-03-27 | Kerrigan Dennis Francis | Officer (Executive Vice President) | Grant / award / vesting | 19 | — | $0 | Form 4 |
| 2026-03-27 | FARBER JEFFREY M | Officer (Executive Vice President) | Grant / award / vesting | 53 | — | $0 | Form 4 |
| 2026-03-27 | Lowsley Denise | Officer (Executive Vice President) | Grant / award / vesting | 12 | — | $0 | Form 4 |
| 2026-03-27 | LOVELY DAVID JOHN | Officer (Executive Vice President) | Grant / award / vesting | 13 | — | $0 | Form 4 |
Ask the chat about THG's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Hanover Insurance (THG).
Last updated 2026-09-25 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.